As the shift in cannabis trends continues, Organigram Holdings (NASDAQ:OGI,TSXV:OGI) credits its US senior listing as a new source of funding from mature investors.
During the Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) Cannabis Expo in Toronto, Greg Engel, CEO of Organigram, talked with the Investing News Network (INN) about the impact the firm has seen since obtaining a NASDAQ listing.
In May, Organigram became the third Canadian marijuana producer to list on the NASDAQ.
Engel told INN one of the determining factors for the company in securing this listing was newfound interest in investment for the company in the US.
“We’ve seen that with larger, more traditional funds entering the space, so by going to the NASDAQ it gives us access to those funds, it gives (investors the) ability to now invest in us as a company.”
The executive said producers in Canada have faced a sobering period of time where investment metrics have shifted from funded capacity to actual results in the Canadian legal space.
“I think where the separation is happening is between the larger, consistent providers like Organigram and some of the smaller companies, and some of those companies are really struggling to access capital now,” he said.
Engel confirmed the company is examining opportunities to access the US market by way of the hemp-derived cannabidiol product space, which has garnered attention from fellow Canadian producers.
For more on what Engel had to say, watch the interview above. You can also click here to see our full Lift & Co. Cannabis Expo playlist on YouTube.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
World High Life Plc (“World High Life” or the “Company”)(AQSE:LIFE) (OTCQB:WRHLF), is pleased to announce that it has appointed H&P Advisory Limited (“Hannam & Partners”) as financial advisor to the Company with immediate effect
About Love Hemp
Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ retail stores, today announced that its executive team will participate in the following conference in March 2021:
Needham 2 nd Annual Virtual Cannabis Conference, March 3, 2021: Management will participate in one-on-one meetings.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.